Emory University Clinic

Atlanta, Georgia 30322

0 studies enrolling now · 8 studies all time

What they study most

AML, Acute Myeloid Leukemia, Basal Cell Carcinoma, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Device Advisory, Device Replacement, Device Upgrade, Elective Replacement (ERI), HER2 Positive Breast Cancer, Postoperative Complications, Staphylococcal Vaccine

Studies at this site

• A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer — Running, not enrolling
• Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation — Stopped early
• A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas — Completed
• Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer — Stopped early
• An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene — Completed
• An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene — Completed
• REPLACE: Implantable Cardiac Pulse Generator Replacement Registry — Completed
• Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML — Completed